Exane Derivatives’s GDS Holdings GDS Stock Holding History

Exane Derivatives’s Portfolio GDS Stock Details GDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,000	Closed	-$232K	–	712
2020 Q1	$232K	Buy	+4,000	New	+$223K	0.06%	181

Other funds holding GDS

STT

Singapore Technologies Telemedia Singapore $295M AUM 1.77% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $8.89B AUM 39.91% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Exane Derivatives's GDS Position: Q2 2020 in Review

Exane Derivatives sold out of GDS Holdings (GDS) in Q2 2020, closing a stake of 4,000 shares — an estimated $232K sold.

Exane Derivatives first reported a position in GDS in Q1 2020 and held it in 1 quarter. The position peaked at $232K in Q1 2020. 250 funds tracked by Wall St. Rank hold GDS as of Q2 2020.

Exane Derivatives reported no remaining GDS Holdings position as of Q2 2020 after selling out during the quarter.
Exane Derivatives sold 4,000 GDS Holdings shares in Q2 2020, an estimated $232K.
Exane Derivatives first reported a position in GDS Holdings in Q1 2020 and held it in 1 quarter.
Exane Derivatives's GDS Holdings position peaked at $232K in Q1 2020.
250 funds tracked by Wall St. Rank held GDS Holdings as of Q2 2020.

Based on Exane Derivatives's 13F filing for Q2 2020, filed 10 Jul 2020.